BrightPath
4594.TBrightPath Biotherapeutics Co., Ltd. Price (4594.T)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
64,162,271
(7.5461)%Cash Flow Statement
BrightPath Biotherapeutics Co., Ltd.Currency: JPY
| YEAR | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||
| Net Income | -408,432,000.00
+0% |
-992,977,000.00
+143% |
-1,116,928,000.00
+12% |
-1,573,292,000.00
+41% |
-1,880,529,000.00
+20% |
-1,859,861,000.00
-1% |
-1,717,214,000.00
-8% |
-1,481,772,000.00
-14% |
-1,483,733,000.00
+0% |
-1,168,082,000.00
-21% |
|||||||||
| Depreciation And Amortiz... | 8.80M | 19.30M | 42.71M | 73.21M | 82.77M | 62.47M | 66.69M | 35.12M | 16.72M | 395.00k | |||||||||
| Deferred Income Tax | 0.00 | 0.00 | 17.55M | -3,046,000.00 | 241.12M | 46.08M | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Stock-Based Compensat... | 0.00 | 0.00 | 20.22M | 34.57M | 14.01M | 872.00k | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Change In Working Capital | |||||||||||||||||||
| Accounts Receivables | 0.00 | -27,150,000.00 | 51.80M | -22,067,000.00 | 76.17M | 181.00k | 376.00k | -16,302,000.00 | 16.53M | 49.00k | |||||||||
| Accounts Payables | 0.00 | 8.39M | -41,142,000.00 | -13,785,000.00 | 19.56M | -27,519,000.00 | -346,000.00 | 1.44M | -1,835,000.00 | -56,000.00 | |||||||||
| Inventory | -13,417,000.00 | 112.26M | -6,070,000.00 | 14.74M | 27.57M | 4.33M | 82.98M | 47.62M | -238,335,000.00 | 0.00 | |||||||||
| Other Working Capital | -20,437,000.00 | -69,250,000.00 | 22.74M | -35,061,000.00 | -5,311,000.00 | 5.82M | -95,196,000.00 | -48,025,000.00 | 240.52M | 2.82M | |||||||||
| Other Non-Cash Items | -13,713,000.00 | 21.95M | -47,726,000.00 | -102,461,000.00 | -32,938,000.00 | -16,825,000.00 | -107,136,000.00 | -50,108,000.00 | 245.74M | 7.95M | |||||||||
| Net Cash Provided By Op... | -447,197,000.00
+0% |
-908,711,000.00
+103% |
-1,067,512,000.00
+17% |
-1,591,336,000.00
+49% |
-1,457,571,000.00
-8% |
-1,784,461,000.00
+22% |
-1,769,848,000.00
-1% |
-1,512,022,000.00
-15% |
-1,204,401,000.00
-20% |
-1,156,920,000.00
-4% |
|||||||||
| Investing Activities | |||||||||||||||||||
| Investments In Propert... | -42,863,000.00 | -32,125,000.00 | -103,842,000.00 | -111,555,000.00 | -175,257,000.00 | -110,132,000.00 | -35,274,000.00 | -17,646,000.00 | -1,760,000.00 | -6,194,000.00 | |||||||||
| Acquisitions Net | 0.00 | 0.00 | 7.28M | 0.00 | -7,200,000.00 | 495.00k | 0.00 | 80.00k | 0.00 | 0.00 | |||||||||
| Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Sales Maturities Of Inve... | 0.00 | 0.00 | 7.28M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Other Investing Activities | -23,991,000.00 | 0.00 | 1,000.00 | -1,000.00 | -2,658,000.00 | 2.76M | -937,000.00 | 0.00 | 0.00 | -1,454,000.00 | |||||||||
| Net Cash Used For Inv... | -66,854,000.00
+0% |
-32,125,000.00
-52% |
-96,564,000.00
+201% |
-111,556,000.00
+16% |
-185,115,000.00
+66% |
-106,879,000.00
-42% |
-36,211,000.00
-66% |
-17,566,000.00
-51% |
-1,760,000.00
-90% |
-7,648,000.00
+335% |
|||||||||
| Financing Activities | |||||||||||||||||||
| Debt Repayment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 87.50M | -87,500,000.00 | 112.50M | |||||||||
| Common Stock Issued | 1.25B | 2.67B | 3.51B | 3.27B | 15.81M | 10.75M | 2.05B | 478.05M | 519.60M | 573.38M | |||||||||
| Common Stock Repurch... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2,228,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Other Financing Activities | 0.00 | 0.00 | 45.10M | 12.17M | 0.00 | -1,000.00 | 585.00k | 3.68M | 0.00 | 5.08M | |||||||||
| Net Cash Used/Provide... | 1.25B
+0% |
2.67B
+114% |
3.56B
+33% |
3.28B
-8% |
15.81M
-100% |
8.52M
-46% |
2.05B
+23,994% |
569.23M
-72% |
432.10M
-24% |
690.96M
+60% |
|||||||||
| Effect Of Forex Changes... | -1,000.00 | -1,000.00 | 0.00 | -1,000.00 | 0.00 | -2,000.00 | 1,000.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Net Change In Cash | 733.66M | 1.73B | 2.40B | 1.58B | -1,626,876,000.00 | -1,882,821,000.00 | 247.03M | -960,362,000.00 | -774,057,000.00 | -473,609,000.00 | |||||||||
| Cash At Beginning Of Per... | 90.07M | 823.74M | 2.56B | 4.95B | 6.53B | 4.90B | 3.02B | 3.27B | 2.31B | 1.53B | |||||||||
| Cash At End Of Period | 823.74M | 2.56B | 4.95B | 6.53B | 4.90B | 3.02B | 3.27B | 2.31B | 1.53B | 1.06B | |||||||||
| Additional Metrics: | |||||||||||||||||||
| Operating Cash Flow | -447,197,000.00 | -908,711,000.00 | -1,067,512,000.00 | -1,591,336,000.00 | -1,457,571,000.00 | -1,784,461,000.00 | -1,769,848,000.00 | -1,512,022,000.00 | -1,204,401,000.00 | -1,156,920,000.00 | |||||||||
| Capital Expenditure | -42,863,000.00 | -32,125,000.00 | -103,842,000.00 | -111,555,000.00 | -175,257,000.00 | -110,132,000.00 | -35,274,000.00 | -17,646,000.00 | -1,760,000.00 | -7,648,000.00 | |||||||||
| Free Cash Flow | -490,060,000.00
+0% |
-940,836,000.00
+92% |
-1,171,354,000.00
+25% |
-1,702,891,000.00
+45% |
-1,632,828,000.00
-4% |
-1,894,593,000.00
+16% |
-1,805,122,000.00
-5% |
-1,529,668,000.00
-15% |
-1,206,161,000.00
-21% |
-1,164,568,000.00
-3% |
|||||||||